GE HealthCare Technologies
GEHC56
$82.44arrow_drop_up0.51%$0.42
S&P500
GEHC56
$82.44
arrow_drop_up0.51%Performance History
| Key Stats | |
|---|---|
| Open | $81.96 |
| Prev. Close | $82.00 |
| EPS | 3.65 |
| Next Earnings Date | Feb 18, 2025 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 80.58 | 83.02 |
| 52 Week Range | 62.35 | 94.55 |
| Ratios | |
|---|---|
| EPS | 3.65 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About GE HealthCare Technologies (GEHC)
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. Peter J. Arduini
- Headquarters
- Chicago
- Employees
- 50000
- Exchange
- NASDAQ
Keep an eye on GE HealthCare Technologies
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is GE HealthCare Technologies's (GEHC) price per share?
The current price per share for GE HealthCare Technologies (GEHC) is $82.44. The stock has seen a price change of $0.42 recently, indicating a 0.51% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for GE HealthCare Technologies (GEHC)?
For GE HealthCare Technologies (GEHC), the 52-week high is $94.55, which is 14.69% from the current price. The 52-week low is $62.35, the current price is 32.22% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is GE HealthCare Technologies (GEHC) a growth stock?
GE HealthCare Technologies (GEHC) has shown an average price growth of -3.66% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GE HealthCare Technologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is GE HealthCare Technologies (GEHC) stock price performance year to date (YTD)?
As of the latest data, GE HealthCare Technologies (GEHC) has a year-to-date price change of 7.95%. Over the past month, the stock has experienced a price change of -7.67%. Over the last three months, the change has been -2.76%. Over the past six months, the figure is 3.92%.
help
Is GE HealthCare Technologies (GEHC) a profitable company?
GE HealthCare Technologies (GEHC) has a net income of $1.57B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 40.52% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.06% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $19.55B, with a revenue growth rate of 6.6%, providing insight into the company's sales performance and growth. The gross profit is $7.92B. Operating income is noted at $2.44B. Furthermore, the EBITDA is $3.47B.
help
What is the market capitalization of GE HealthCare Technologies (GEHC)?
GE HealthCare Technologies (GEHC) has a market capitalization of $37.66B. The average daily trading volume is 81.76, indicating the stock's liquidity and investor engagement.
News
HONEYWELL
ELLIOTT INVESTMENT MANAGEMENT
CONGLOMERATE
BREAKUP
AEROSPACE
AUTOMATION
Honeywell Just Hit an All-Time High: Could Breaking Up This Dow Dividend Stock Unlock Even More Value?
CELL LINE DEVELOPMENT
BIOPHARMACEUTICALS
BIOLOGICS
RECOMBINANT CELL LINES
NORTH AMERICA
Cell Line Development Market to Surpass Market Valuation of USD 15.88 Billion by 2031 | SkyQuest Technology
CELL LINE DEVELOPMENT
BIOPHARMACEUTICALS
BIOLOGICS
MONOCLONAL ANTIBODIES
BIOSIMILARS
Cell Line Development Market to Surpass Market Valuation of USD 15.88 Billion by 2031 | SkyQuest Technology
NEUROSCIENCE
NEUROLOGICAL DISORDERS
MEDICAL TECHNOLOGY
BRAIN-COMPUTER INTERFACES
AI
MACHINE LEARNING
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider
GE HEALTHCARE
DEEPHEALTH
AI
BREAST CANCER SCREENING
IMAGING
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HEALTHCARE
RADNET
DEEPHEALTH
AI
IMAGING
RADIOLOGY
MAMMOGRAPHY
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™